Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early ARNI versus ACE inhibitor after acute ST-elevation myocardial infarction
IRCT20251114067992N1Phase 3Recruiting
- Sponsor
- Guilan University of Medical Sciences
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of sacubitril + valsartan, sponsored by Guilan University of Medical Sciences. Started Dec 2025; status: recruiting.
02
Drugs
sacubitril + valsartan
Beyond the preview
Go deeper on IRCT20251114067992N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251114067992N1.